EP Edge Journal Watch
Episodes
EP Edge™ Journal Watch Issue 19: Atrial Fibrillation Ablation, Conduction System Pacing, GLP-1 Therapy and Arrhythmia Risk
20 Apr 2026
Contributed by Lukas
In EP Edge™ Journal Watch Issue 19, Dr. Sharma reviews the most important new studies in atrial fibrillation ablation, conduction system pacing, dev...
EP Edge™ Journal Watch Special Edition: EHRA PFA Statement 2026 | What the New Guidance Means for AF Ablation
14 Apr 2026
Contributed by Lukas
In this special edition of EP Edge™ Journal Watch, Dr. Sharma takes a focused, critical look at the 2026 EHRA/ESC scientific statement on pulsed fie...
EP Edge™ Journal Watch Issue 18 (April 2026): AF Cancer Signals, PFA Recalibration, EMBOL-AF, SMART-ALERT, LBBAP, and VT Rescue
13 Apr 2026
Contributed by Lukas
In EP Edge™ Journal Watch Issue 19 (April 2026), Dr. Niraj Sharma takes a high-level look at the latest developments in cardiac electrophysiology, w...
EP Edge Journal Watch Issue 17 April 2026: CLOSURE-AF, Left Atrial Appendage Closure vs Medical Therapy, CRT Pacing Trials, PFA Cerebral Emboli, and ViV-TAVR Pacemaker Risk
06 Apr 2026
Contributed by Lukas
In this episode of EP Edge Journal Watch, Dr. Niraj Sharma reviews five clinically important studies spanning atrial fibrillation, structural heart in...
EP Edge™ Journal Watch Breaking News Special Edition: CHAMPION-AF, PRAGUE-17, and CLOSURE-AF — LAAC vs DOACs in Atrial Fibrillation
30 Mar 2026
Contributed by Lukas
In this EP Edge™ Journal Watch Breaking News Special Edition, Dr. Niraj Sharma delivers an in-depth analysis of the CHAMPION-AF trial and places its...
EP Edge Journal Watch Issue 16: 11 New EP Trials on AF Ablation, SVT, Anticoagulation, PFA Safety, VT Pacing, and OHCA
23 Mar 2026
Contributed by Lukas
In this episode of EP Edge Journal Watch, Dr. Sharma reviews 11 important new studies shaping modern cardiac electrophysiology, arrhythmia care, and c...
EP Edge™ Journal Watch Issue 15: PFA Recurrence, Bayesian AF Ablation, Non-PV Triggers, Diltiazem-DOAC Risk, and Stroke Prevention After AF Ablation
16 Mar 2026
Contributed by Lukas
In EP Edge™ Journal Watch Issue 15, Dr. Niraj Sharma reviews some of the most important new studies in electrophysiology and atrial fibrillation man...
EP Edge Journal Watch #14 (March 2026): AF Ablation at the Extremes: Octogenarians, HFrEF PVI-Only, LAAC, PFA Hemolysis/AKI & Redo Timing
09 Mar 2026
Contributed by Lukas
In EP Edge Journal Watch Issue 14 (March 2026), Dr. Niraj Sharma breaks down the most clinically “edge-case” decisions in contemporary electrophys...
EP Edge Journal Watch Issue 13 (March 2026): Ultrashort AF, ILR Accuracy, Semaglutide + Ablation, PADIT, PCOS, LBBAP and Next-Gen nanosecond PFA (SCENA-AF)
02 Mar 2026
Contributed by Lukas
EP Edge Journal Watch — Issue 13 (March 2026) explores a core 2026 EP problem: signal detection (wearables, patches, ILRs) and energy delivery (next...
EP Edge™ Journal Watch: February 2026 Issue 12: AF Ablation “Success” Reframed: ADVENT-LTO 4-Year PFA Durability, 20-Year PVI Outcomes, Monitoring Rules, CIED Risks & PICM
23 Feb 2026
Contributed by Lukas
In this episode of EP Edge™ Journal Watch (Issue 12, February 2026), Dr. Niraj Sharma breaks down a deceptively simple question in atrial fibrilla...
EP Edge™ Journal Watch (Special Edition): Feb 2026 HRS/EHRA Pulsed Field Ablation (PFA) Scientific Statement — Vote Counts, Safety Signals, and Real-World Workflow
19 Feb 2026
Contributed by Lukas
In this EP Edge™ Journal Watch Special Edition, we unpack the newly released 2026 HRS/EHRA Scientific Statement on Pulsed Field Ablation (PFA) and t...
EP Edge Journal Watch Issue 11 February 2026: Varipulse Safety Signal, ElectroPulse PFA, Farapoint CTI Ablation, Leadless Pacemaker Infection & EP Occupational Hazards
16 Feb 2026
Contributed by Lukas
In this episode of EP Edge Journal Watch, we review several developments that directly impact modern electrophysiology practice — from pulsed field ...
EP Edge Journal Watch Issue 10, February 2026: Pulsed Field Ablation Durability, AF Ablation Outcomes, Wearable AF Detection, ICD and VT Insights
09 Feb 2026
Contributed by Lukas
EP Edge Journal Watch: Feb 2026 Issue 10In this episode of EP Edge Journal Watch, we examine the latest developments shaping the future of cardiac ele...
EP Edge Journal Watch Special Edition: VOLT IDE One-Year Results in Context: ADVENT, ADVANTAGE-AF, AdmIRE, SPHERE-Per-AF & U.S. PFA Pivotal Trials
06 Feb 2026
Contributed by Lukas
Pulsed field ablation (PFA) has rapidly reshaped atrial fibrillation ablation, but true clinical validation depends on durable one-year outcomes, not ...
EP Edge Journal Watch — Issue 9 Redefining Ventricular Tachycardia Care: From Noninvasive Radioablation to Leadless, Modular, and Drug-Based Strategies
02 Feb 2026
Contributed by Lukas
In EP Edge Journal Watch – Issue 9 (February 2026), we take a comprehensive, clinically grounded look at the evolving management of ventricular tach...
EP Edge Journal Watch – Issue 8 (2026): VT Storm Outcomes, Inappropriate ICD Shocks, AF Ablation Modifiers, and the Rise of Patient-Directed SVT Care
26 Jan 2026
Contributed by Lukas
In EP Edge Journal Watch – Issue 8 (2026), we deliver a comprehensive, evidence-driven analysis of the most important and practice-shaping studies i...
EP-EDGE Journal Watch #7: Direct Oral Anti-Coagulant Adherence, AF Risk Stressors, ns-PFA Safety & EP Device Updates
19 Jan 2026
Contributed by Lukas
EP-EDGE Journal Watch – Issue 7 (January 2026)Advanced Cardiac Electrophysiology Podcast | AF, DOACs, PFA, Devices & Heart FailureIn EP-EDGE Jou...
LAAO vs Anticoagulation Explained: WATCHMAN FLX, AF Ablation Recurrence, Post-TAVR Heart Block & ICU AF, Hormones and TdP – EP Edge Journal Watch
12 Jan 2026
Contributed by Lukas
EP Edge Journal Watch Podcast — Issue 6 (January 2026)Left Atrial Appendage Occlusion, AF Ablation Insights, Post-TAVR Conduction, ICU Anticoagulati...
Pulsed Field Ablation, Atrial Fibrillation Progression & Leadless Pacing | EP Edge Journal Watch – Jan 2026 (Issue 5)
05 Jan 2026
Contributed by Lukas
EP Edge Journal Watch — January 2026 | Issue #5Pulsed Field Ablation, Device Therapy, and the Era of Personalized EPWelcome to EP Edge Journal Watch...
AF Beyond the Lesion: Can We Stop Anticoagulation, Trust Sham Trials, and Treat AF as a Metabolic Disease?
18 Dec 2025
Contributed by Lukas
In this December 2025 episode of EP Edge Journal Watch, Dr. Niraj Sharma breaks down the most provocative atrial fibrillation trials of the year—stu...
EP Edge Journal Watch Issue 3: Smartwatch AFib Detection: Accuracy, False Alerts, Apple Watch ECG, and What Clinicians Need to Know
30 Nov 2025
Contributed by Lukas
Smartwatches are now among the most widely used heart-monitoring tools in the world — but how accurate are they really at detecting AFib? In this De...
EP Edge Journal Watch: Critical Analysis: AQUATIC Trial — AF + CAD: Impact on Antithrombotic Strategy (NEJM October 2025)
10 Nov 2025
Contributed by Lukas
In this special EP Edge Journal Watch episode, Dr. Niraj Sharma delivers a critical analysis of the landmark AQUATIC Trial, published in the New Engla...
EP Edge Journal Watch — November 2025, Edition 2: From Lifestyle to Lifeline
02 Nov 2025
Contributed by Lukas
In this episode, Dr. Niraj Sharma breaks down six pivotal studies shaping today’s electrophysiology and cardiology practice—from lifestyle-driven ...
EP Edge Journal Watch | Episode 1, November 2025: Potassium and VT, GDMT Withdrawal & AF Risk Uncovered
30 Oct 2025
Contributed by Lukas
In this inaugural episode, Dr. Niraj Sharma breaks down three pivotal studies that could shift daily EP practice:How high-normal potassium targeting c...